Science minister opens new Pfizer facility in Havant
March 13, 2012Manufacturing and Production Havant, Pfizer, R&D, Tucker, Willetts
Science minister David Willetts has opened Pfizer’s new state-of-the-art cold storage facility at its site in Havant. The new £7 …
Catalent continues investment in Global Clinical Supply services with German warehousing & controlled substance expansion
March 13, 2012Research and Development
Somerset, NJ – March 7, 2012 — Catalent Pharma Solutions announced the completion of extended warehousing facilities in Schorndorf, Germany …
Catalent Expert Presents on Protein Expression in CHO Cells: Comparison of GPEx® Technology to Traditional Cell Line Engineering at Cell Culture World Congress 2012
March 13, 2012Research and Development
Somerset, NJ February 21, 2012 — Michael Jenkins, Ph.D., General Manager of Catalent Pharma Solutions’ Middleton, WI facility, will present …
MHRA plans to cut red tape in the UK
March 13, 2012Manufacturing and Production EU, MHRA, pharma
The UK government’s drug safety regulator is calling on the pharma industry to help it eliminate unneccessary bureaucracy.The Medicines and …
Dr John Brown joins BioCity Nottingham’s board
March 13, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BioCity Nottingham, BioCity Scotland, John Brown
Dr John Brown has been appointed as a non-executive director to the board of BioCity Nottingham Ltd, which runs one …
GSK expands apprenticeship programme
March 13, 2012Manufacturing and Production, Research and Development GSK, Hayes, R&D, manufacturing
GlaxoSmithKline has expanded its apprenticeship programme with the creation of positions spanning manufacturing, IT, and R&D. The multi-disciplinary scheme is …
NICE wants more information on Xarelto
March 13, 2012Sales and Marketing Bayer, DVT, NICE, Xarelto
NICE is asking Bayer for more information about its blood thinner Xarelto in new guidance. The watchdog is currently minded …
Sanofi’s new diabetes device: worth the price?
March 12, 2012Medical Communications NHS, Sanofi, app, diabetes, iBGStar, smartphone
Sanofi launched its new iPhone and iPod Touch blood sugar monitor to much fanfare this week, but its high price …
WHO joins regulators in manufacturing inspections alliance
March 12, 2012Manufacturing and Production API, EMA, FDA, WHO, manufacturing
The World Health Organization will join a shared inspection programme for active pharmaceutical ingredient (API) facilities piloted last year by …
Strong Zytiga study results could increase uptake
March 12, 2012Research and Development, Sales and Marketing IDMC, Janssen, Provenge, Zytiga, prostate
Janssen’s prostate cancer pill Zytiga could be on course to target a larger number of patients following a positive late-stage …
Sanofi launches iPhone and iPod glucose monitor in the UK
March 12, 2012Medical Communications, Sales and Marketing BGStar, Sanofi, diabetes, iPod, iphone
Sanofi has launched a new diabetes device in the UK to help patients monitor their blood sugar levels from their …
Patheon swings to loss on terminated manufacturing contract
March 12, 2012Manufacturing and Production Patheon, fiscal, manufacturing, operating
Contract manufacturing and development organisation Patheon said it posted an operating loss in its fiscal first quarter results after losing …
UCB chief executive to chair IMI
March 12, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing IMI, Roch, UCB
UCB has confirmed that its chief executive Roch Doliveux has been appointed chairman of the governing board of the Innovative …
Prescription drugs could become OTC under FDA plans
March 12, 2012Sales and Marketing COPD, FDA, OTC, prescribing
The FDA is considering new plans to make drugs for chronic conditions available over-the-counter. These drugs could include medicines for …
India’s Nexavar patent ruling disturbs pharma
March 12, 2012Sales and Marketing India, emerging markets, intellectual property, patents
India is to allow Bayer’s cancer treatment Nexavar to be subject to a compulsory licence, allowing a generic firm to …
Government could be forced to publish risk register
March 9, 2012Sales and Marketing Healey, NHS, reforms, risk
The government has lost its appeal to keep details about the risks involved in the reform of the NHS secret. …
Major new drugs for 2012
March 9, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Caprelsa, Eylea, Manjor new drugs, Xalkori, Zelboraf, avastin, inlyta
Renal cell carcinoma Pfizer’s Inlyta (axitinib) has been approved as second line treatment for renal cell carcinoma. The drug is …
Battle against prostate cancer gains celebrity endorsement
March 9, 2012Medical Communications M&S, MS, Vader, prostate
A famous DJ and a legendary Star Wars actor have joined forces to raise awareness of prostate cancer. Star Wars …
inVentiv appoints former Quintiles man Mark Archer
March 9, 2012Business Services, Medical Communications, Sales and Marketing Merck, Quintiles, Roche, Sanofi, inVentiv
Pharma consultants inVentiv Health has appointed Mark as its new senior vice president of European operations and development for inVentiv …
Government touts telehealth scheme
March 9, 2012Medical Communications, Sales and Marketing NHS, king's fund, telecare, telehealth
The government has said that telehealth and telecare technology could save the NHS £1.2 billion over the next five years. …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
